688253 英诺特
已收盘 09-24 15:00:00
资讯
新帖
简况
股市必读：英诺特生物股份新发布《2026年第一次临时股东会会议资料》
证券之星 · 09-24 02:30
股市必读：英诺特生物股份新发布《2026年第一次临时股东会会议资料》
英诺特（688253）披露限制性股票激励计划部分归属结果暨股份上市公告，9月23日股价上涨0.21%
证券之星 · 09-23
英诺特（688253）披露限制性股票激励计划部分归属结果暨股份上市公告，9月23日股价上涨0.21%
每周股票复盘：英诺特（688253）获6项产品资质
证券之星 · 09-06
每周股票复盘：英诺特（688253）获6项产品资质
股市必读：英诺特新发布《关于公司及子公司近期获得资质情况的自愿披露公告》
证券之星 · 09-04
股市必读：英诺特新发布《关于公司及子公司近期获得资质情况的自愿披露公告》
英诺特（688253）披露公司及子公司近期获得资质情况，9月2日股价上涨1.82%
证券之星 · 09-02
英诺特（688253）披露公司及子公司近期获得资质情况，9月2日股价上涨1.82%
每周股票复盘：英诺特（688253）Q2净利亏损951万同比降131.95%
证券之星 · 08-30
每周股票复盘：英诺特（688253）Q2净利亏损951万同比降131.95%
英诺特（688253）2026年中报简析：净利润同比下降75.12%，三费占比上升明显
证券之星 · 08-28
英诺特（688253）2026年中报简析：净利润同比下降75.12%，三费占比上升明显
股市必读：英诺特新发布《2026年半年度报告摘要》
证券之星 · 08-28
股市必读：英诺特新发布《2026年半年度报告摘要》
英诺特（688253）披露2026年半年度报告，8月26日股价下跌0.37%
证券之星 · 08-26
英诺特（688253）披露2026年半年度报告，8月26日股价下跌0.37%
英诺特(688253.SH)发布半年度业绩，归母净利润3112万元，同比下降75.12%
智通财经 · 08-26
英诺特(688253.SH)发布半年度业绩，归母净利润3112万元，同比下降75.12%
股市必读：英诺特新发布《关于公司及子公司近期获得资质情况的自愿披露公告》
证券之星 · 08-10
股市必读：英诺特新发布《关于公司及子公司近期获得资质情况的自愿披露公告》
每周股票复盘：英诺特（688253）获多项产品资质及工商变更
证券之星 · 08-09
每周股票复盘：英诺特（688253）获多项产品资质及工商变更
英诺特（688253）披露公司及子公司近期获得资质情况的自愿披露公告，8月7日股价上涨7.8%
证券之星 · 08-07
英诺特（688253）披露公司及子公司近期获得资质情况的自愿披露公告，8月7日股价上涨7.8%
股市必读：英诺特新发布《关于完成工商变更登记并换发营业执照的公告》
证券之星 · 08-05
股市必读：英诺特新发布《关于完成工商变更登记并换发营业执照的公告》
股市必读：英诺特新发布《关于完成工商变更登记并换发营业执照的公告》
证券之星 · 08-04
股市必读：英诺特新发布《关于完成工商变更登记并换发营业执照的公告》
英诺特与淘宝闪购、阿里健康、九州通、蚂蚁阿福达成战略合作
智通财经 · 07-23
英诺特与淘宝闪购、阿里健康、九州通、蚂蚁阿福达成战略合作
每周股票复盘：英诺特（688253）获6项产品资质
证券之星 · 07-05
每周股票复盘：英诺特（688253）获6项产品资质
英诺特（688253）披露公司及子公司近期获得资质情况的自愿披露公告，6月29日股价上涨1.17%
证券之星 · 06-29
英诺特（688253）披露公司及子公司近期获得资质情况的自愿披露公告，6月29日股价上涨1.17%
英诺特：公司2025年年度业绩说明会已于2026年5月13日以上证路演中心网络互动方式召开
证券之星 · 06-03
英诺特：公司2025年年度业绩说明会已于2026年5月13日以上证路演中心网络互动方式召开
每周股票复盘：英诺特（688253）2025年度股东会多项议案获通过
证券之星 · 05-24
每周股票复盘：英诺特（688253）2025年度股东会多项议案获通过
公司概况
公司名称：
北京英诺特生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2022-07-28
主营业务：
北京英诺特生物技术股份有限公司的主营业务是体外诊断快速诊断产品研发、生产和销售。公司的主要产品是呼吸道系列、消化道系列、优生优育系列、神经系统系列。公司于2025年获得国家级专精特新“小巨人”企业认定。
发行价格：
26.06
{"stockData":{"symbol":"688253","market":"SH","secType":"STK","nameCN":"英诺特","latestPrice":57.1,"timestamp":1790233200000,"preClose":57.79,"halted":0,"volume":955052,"delay":0,"changeRate":-0.0119,"floatShares":137000000,"shares":138000000,"eps":0.3662,"marketStatus":"已收盘","change":-0.69,"latestTime":"09-24 15:00:00","open":57.21,"high":58.39,"low":57,"amount":55057800,"amplitude":0.0241,"askPrice":57.1,"askSize":245,"bidPrice":57,"bidSize":39,"shortable":0,"etf":0,"ttmEps":0.3662,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790559000000},"marketStatusCode":5,"adr":0,"adjPreClose":57.79,"symbolType":"stock_kcb","openAndCloseTimeList":[[1790213400000,1790220600000],[1790226000000,1790233200000]],"highLimit":63.57,"lowLimit":52.01,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":137968284,"isCdr":false,"pbRate":3.88,"roa":"--","peRate":155.925724,"roe":"1.47%","epsLYR":1.06,"committee":-0.48415,"marketValue":7878000000,"turnoverRate":0.007,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-28。","afterMarket":{"amount":0,"volume":0,"close":57.1,"buyVolume":0,"sellVolume":0,"time":1790235237746,"indexStatus":"已收盘 09-24 15:30:00","preClose":57.79},"floatMarketCap":7822000000},"requestUrl":"/m/hq/s/688253/wiki","defaultTab":"wiki","newsList":[{"id":"2669433411","title":"股市必读：英诺特生物股份新发布《2026年第一次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669433411","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669433411?lang=zh_cn&edition=full","pubTime":"2026-09-24 02:30","pubTimestamp":1790188237,"startTime":"0","endTime":"0","summary":"公司公告汇总：公司将于2026年10月20日召开第一次临时股东大会，审议第三届董事会换届选举议案，采用累积投票制。关于2023年限制性股票激励计划首次授予部分第三个归属期、预留授予部分第二个归属期及2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市的公告北京英诺特生物技术股份有限公司完成2023年及2025年限制性股票激励计划的部分归属，共计983,968股股份上市流通，上市日期为2026年9月29日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400002498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0077","BK0188","688253","BK0012","BK0196","BK0185","600201","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669991484","title":"英诺特（688253）披露限制性股票激励计划部分归属结果暨股份上市公告，9月23日股价上涨0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669991484","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669991484?lang=zh_cn&edition=full","pubTime":"2026-09-23 22:26","pubTimestamp":1790173580,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，英诺特报收于57.79元，较前一交易日上涨0.21%，最新总市值为79.16亿元。近日，北京英诺特生物技术股份有限公司披露《关于2023年限制性股票激励计划首次授予部分第三个归属期、预留授予部分第二个归属期及2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市的公告》。公告显示，公司完成2023年及2025年限制性股票激励计划的部分归属，共计983,968股股份上市流通，上市日期为2026年9月29日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300041171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665122365","title":"每周股票复盘：英诺特（688253）获6项产品资质","url":"https://stock-news.laohu8.com/highlight/detail?id=2665122365","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665122365?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:06","pubTimestamp":1788631574,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，英诺特报收于57.09元，较上周的55.65元上涨2.59%。本周，英诺特9月3日盘中最高价报60.15元。英诺特当前最新总市值78.2亿元，在医疗器械板块市值排名40/129，在两市A股市值排名2244/5214。本周关注点公司公告汇总：英诺特及子公司近期获得6项产品资质公司公告汇总北京英诺特生物技术股份有限公司及子公司近期获得6项产品资质，包括3项中国医疗器械注册证、1项越南产品注册证和2项泰国产品注册证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664054138","title":"股市必读：英诺特新发布《关于公司及子公司近期获得资质情况的自愿披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664054138","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664054138?lang=zh_cn&edition=full","pubTime":"2026-09-04 01:17","pubTimestamp":1788455829,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘，英诺特报收于58.89元，上涨3.46%，换手率1.54%，成交量2.1万手，成交额1.23亿元。公司公告汇总关于公司及子公司近期获得资质情况的自愿披露公告北京英诺特生物技术股份有限公司及子公司近期获得6项产品资质，包括3项中国医疗器械注册证、1项越南产品注册证和2项泰国产品注册证。获批产品涉及磷酸化Tau蛋白、神经丝轻链蛋白测定试剂盒及登革热、肺炎支原体、妊娠快速检测试剂盒。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400001848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664105718","title":"英诺特（688253）披露公司及子公司近期获得资质情况，9月2日股价上涨1.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664105718","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664105718?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:47","pubTimestamp":1788360433,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，英诺特报收于56.92元，较前一交易日上涨1.82%，最新总市值为77.97亿元。该股当日开盘55.72元，最高57.6元，最低54.51元，成交额达8580.77万元，换手率为1.12%。近日，英诺特发布《关于公司及子公司近期获得资质情况的自愿披露公告》。公告显示，北京英诺特生物技术股份有限公司及子公司近期获得6项产品资质，包括3项中国医疗器械注册证、1项越南产品注册证和2项泰国产品注册证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663010781","title":"每周股票复盘：英诺特（688253）Q2净利亏损951万同比降131.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663010781","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663010781?lang=zh_cn&edition=full","pubTime":"2026-08-30 04:13","pubTimestamp":1788034389,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，英诺特报收于55.65元，较上周的56.23元下跌1.03%。本周，英诺特8月28日盘中最高价报57.48元。英诺特当前最新总市值76.23亿元，在医疗器械板块市值排名44/129，在两市A股市值排名2296/5211。股本股东变化截至2026年6月30日，英诺特股东户数为5128.0户，较3月31日减少1012.0户，减幅16.48%。业绩披露要点英诺特2026年中报显示，上半年主营收入1.41亿元，同比下降49.09%；归母净利润3111.59万元，同比下降75.12%；扣非净利润1963.87万元，同比下降82.31%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662360710","title":"英诺特（688253）2026年中报简析：净利润同比下降75.12%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2662360710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662360710?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:18","pubTimestamp":1787869118,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期英诺特发布2026年中报。截至本报告期末，公司营业总收入1.41亿元，同比下降49.09%，归母净利润3111.59万元，同比下降75.12%。本报告期英诺特三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达78.31%。然而去年的净利率为34.23%，算上全部成本后，公司产品或服务的附加值极高。本文数据来源于英诺特2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800010962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662358290","title":"股市必读：英诺特新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662358290","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662358290?lang=zh_cn&edition=full","pubTime":"2026-08-28 04:57","pubTimestamp":1787864228,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，英诺特报收于54.29元，下跌0.02%，换手率1.27%，成交量1.74万手，成交额9386.13万元。公司公告汇总：2026年半年度报告摘要显示，公司上半年营业总收入同比下降49.09%，归属于上市公司股东的净利润同比下降75.12%。关于召开2026年半年度业绩说明会的公告公司将于2026年9月10日16:00–17:00通过上证路演中心召开2026年半年度业绩说明会；投资者可于9月3日至9月9日16:00前通过上证","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800009479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662103797","title":"英诺特（688253）披露2026年半年度报告，8月26日股价下跌0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662103797","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662103797?lang=zh_cn&edition=full","pubTime":"2026-08-26 22:16","pubTimestamp":1787753798,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘，英诺特报收于54.3元，较前一交易日下跌0.37%，最新总市值为74.38亿元。该股当日开盘54.5元，最高56.99元，最低53.61元，成交额达1.02亿元，换手率为1.36%。近日，北京英诺特生物技术股份有限公司披露《2026年半年度报告》。公告显示，公司2026年上半年实现营业总收入140,725,359.19元，同比下降49.09%；归属于上市公司股东的净利润31,115,863.15元，同比下降75.12%；扣除非经常性损益后的净利润19,638,693.63元，同比下降82.31%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600052535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662790301","title":"英诺特(688253.SH)发布半年度业绩，归母净利润3112万元，同比下降75.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662790301","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662790301?lang=zh_cn&edition=full","pubTime":"2026-08-26 18:29","pubTimestamp":1787740178,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英诺特(688253.SH)披露2026年半年度报告，报告期公司实现营业收入1.41亿元，同比下降49.09%;归属于上市公司股东的净利润3112万元，同比下降75.12%;归属于上市公司股东的扣除非经常性损益的净利润1964万元，同比下降82.31%;基本每股收益0.23元。公司上半年受呼吸道疾病流行强度变化、体外诊断市场竞争加剧等因素影响，公司营业收入及毛利率有所下降，并导致利润、现金流相关财务指标同比有所下降。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486156.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"英诺特(688253.SH)发布半年度业绩，归母净利润3112万元，同比下降75.12%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658670903","title":"股市必读：英诺特新发布《关于公司及子公司近期获得资质情况的自愿披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658670903","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658670903?lang=zh_cn&edition=full","pubTime":"2026-08-10 01:18","pubTimestamp":1786295891,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，英诺特报收于71.02元，上涨7.8%，换手率3.36%，成交量4.6万手，成交额3.15亿元。当日关注点交易信息汇总：8月7日主力资金净流入1473.49万元，占总成交额4.67%。公司公告汇总：英诺特及子公司近期获3项新产品资质，并完成呼吸道合胞病毒、腺病毒抗原联合检测试剂盒变更注册，新增鼻拭子采样及消费者自测适用范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658673216","title":"每周股票复盘：英诺特（688253）获多项产品资质及工商变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2658673216","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658673216?lang=zh_cn&edition=full","pubTime":"2026-08-09 01:57","pubTimestamp":1786211833,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，英诺特报收于71.02元，较上周的57.15元上涨24.27%。本周，英诺特8月7日盘中最高价报71.23元，股价触及近一年最高点。英诺特当前最新总市值97.29亿元，在医疗器械板块市值排名31/129，在两市A股市值排名1858/5205。注册资本变更为13,698.4316万元，其他登记事项如公司名称、类型、法定代表人、住所、经营范围等均保持不变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657308644","title":"英诺特（688253）披露公司及子公司近期获得资质情况的自愿披露公告，8月7日股价上涨7.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657308644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657308644?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:15","pubTimestamp":1786112137,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，英诺特报收于71.02元，较前一交易日上涨7.8%，最新总市值为97.29亿元。该股当日开盘66.28元，最高71.23元，最低64.7元，成交额达3.15亿元，换手率为3.36%。上述资质提升了公司产品种类与市场竞争力，但实际销售受多种因素影响，业绩贡献存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700040877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657329565","title":"股市必读：英诺特新发布《关于完成工商变更登记并换发营业执照的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657329565","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657329565?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:34","pubTimestamp":1785868454,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，英诺特报收于56.03元，上涨0.38%，换手率0.56%，成交量7684.0手，成交额4325.42万元。当日关注点交易信息汇总：8月4日主力资金净流出210.56万元，占总成交额4.87%。公司公告汇总：英诺特完成工商变更登记，注册资本变更为13,698.4316万元，并已换发新营业执照。公司注册资本变更为13,698.4316万元；统一社会信用代码、名称、类型、法定代表人、住所、经营范围等其他登记事项保持不变。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656032143","title":"股市必读：英诺特新发布《关于完成工商变更登记并换发营业执照的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656032143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656032143?lang=zh_cn&edition=full","pubTime":"2026-08-04 01:07","pubTimestamp":1785776830,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，英诺特报收于55.82元，下跌2.33%，换手率1.07%，成交量1.47万手，成交额8300.01万元。公司公告汇总关于完成工商变更登记并换发营业执照的公告北京英诺特生物技术股份有限公司于2026年4月26日和5月21日分别召开第二届董事会第十四次会议及2025年年度股东会，审议通过变更注册资本、修订《公司章程》并办理工商登记的议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400001075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653728842","title":"英诺特与淘宝闪购、阿里健康、九州通、蚂蚁阿福达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2653728842","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653728842?lang=zh_cn&edition=full","pubTime":"2026-07-23 20:39","pubTimestamp":1784810379,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649969446","title":"每周股票复盘：英诺特（688253）获6项产品资质","url":"https://stock-news.laohu8.com/highlight/detail?id=2649969446","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649969446?lang=zh_cn&edition=full","pubTime":"2026-07-05 02:36","pubTimestamp":1783190173,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，英诺特报收于62.85元，较上周的58.0元上涨8.36%。本周，英诺特7月1日盘中最高价报66.2元。6月29日盘中最低价报55.8元。英诺特当前最新总市值86.09亿元，在医疗器械板块市值排名37/129，在两市A股市值排名2190/5203。本周关注点公司公告汇总：英诺特及子公司近期获得6项产品资质。公司公告汇总北京英诺特生物技术股份有限公司及子公司近期获得6项产品资质，包括1项缅甸产品文号和5项中国医疗器械注册证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647786183","title":"英诺特（688253）披露公司及子公司近期获得资质情况的自愿披露公告，6月29日股价上涨1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647786183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647786183?lang=zh_cn&edition=full","pubTime":"2026-06-29 18:01","pubTimestamp":1782727274,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘，英诺特报收于58.68元，较前一交易日上涨1.17%，最新总市值为80.38亿元。该股当日开盘57.7元，最高59.02元，最低55.8元，成交额达1.21亿元，换手率为1.54%。近日，北京英诺特生物技术股份有限公司及子公司近期获得6项产品资质，包括1项缅甸产品文号和5项中国医疗器械注册证。上述资质有助于提升公司市场拓展能力与核心竞争力，但实际销售及业绩影响存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900028703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640746019","title":"英诺特：公司2025年年度业绩说明会已于2026年5月13日以上证路演中心网络互动方式召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2640746019","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640746019?lang=zh_cn&edition=full","pubTime":"2026-06-03 15:37","pubTimestamp":1780472252,"startTime":"0","endTime":"0","summary":"证券之星消息，英诺特06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，我注意到贵公司在2024年未提供业绩说明会视频回放。公司2025年年度业绩说明会已于2026年5月13日以上证路演中心网络互动方式召开，具体会议内容请详见公司披露的《英诺特2026年5月13日投资者关系活动记录表》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300026580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637373478","title":"每周股票复盘：英诺特（688253）2025年度股东会多项议案获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2637373478","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637373478?lang=zh_cn&edition=full","pubTime":"2026-05-24 02:52","pubTimestamp":1779562331,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：英诺特2025年年度股东会审议通过利润分配方案、续聘审计机构及修订公司章程等议案。公司公告汇总北京市中伦律师事务所就北京英诺特生物技术股份有限公司2025年年度股东会的合法性出具法律意见书。北京英诺特生物技术股份有限公司于2026年5月21日召开2025年年度股东会，会议由董事长叶逢光主持，出席会议的股东及代理人共50人，代表有表决权股份总数的55.3957%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790447260508,"stockEarnings":[{"period":"1week","weight":0.0574},{"period":"1month","weight":0.0477},{"period":"3month","weight":-0.0155},{"period":"6month","weight":0.5764},{"period":"1year","weight":0.8544},{"period":"ytd","weight":0.906}],"compareEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":-0.0003},{"period":"3month","weight":-0.0345},{"period":"6month","weight":-0.0065},{"period":"1year","weight":0.009},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京英诺特生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"5128人(较上一季度减少16.48%)","perCapita":"26904股","listingDate":"2022-07-28","address":"北京市丰台区海鹰路1号院6号楼1层2层","registeredCapital":"13796万元","survey":" 北京英诺特生物技术股份有限公司的主营业务是体外诊断快速诊断产品研发、生产和销售。公司的主要产品是呼吸道系列、消化道系列、优生优育系列、神经系统系列。公司于2025年获得国家级专精特新“小巨人”企业认定。","listedPrice":26.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"英诺特(688253)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供英诺特(688253)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"英诺特,688253,英诺特股票,英诺特股票老虎,英诺特股票老虎国际,英诺特行情,英诺特股票行情,英诺特股价,英诺特股市,英诺特股票价格,英诺特股票交易,英诺特股票购买,英诺特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"英诺特(688253)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供英诺特(688253)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}